Підписатись
Ірина Драпак
Ірина Драпак
професор, доктор фармацевтичних наук, Львівський національний медичний університет імені Данила
Підтверджена електронна адреса в meduniv.lviv.ua
Назва
Посилання
Посилання
Рік
QSAR studies of some thiazolo [4, 5-b] pyridines as novel antioxidant agents: enhancement of activity by some molecular structure parameters
O Klenina, I Drapak, T Chaban, V Ogurtsov, I Chaban, I Golos
Chemistry and Chemical Technology 7 (4), 397-404, 2013
312013
Synthesis of Some Novel Thiazolo (4, 5-b) Pyridinesand their Tuberculostatic Activity Evaluation
T Chaban, O Klenina, I Drapak, V Ogurtsov, I Chaban, V Novikov
Chemistry & Chemical Technology, 287-292, 2014
292014
Modern trends in diuretics development
T Titko, L Perekhoda, I Drapak, Y Tsapko
European Journal of Medicinal Chemistry 208, 112855, 2020
152020
Synthesis of 2-(4-aryl (adamantyl)-2-phenylіmіnothіazol-3-yl)-ethanol derivatives and prediction of their biological activity
HO Yeromina, IV Drapak, LO Perekhoda, VD Yaremenko, ...
Der Pharma Chemica, 2016
152016
Synthesis antimicrobial and antitumor activities of 2-[5-(2-R-benzyl) thiazol-2-ylimino] thiazolidin-4-ones
I Drapak, T Chaban, V Foliush, V Matiychuk
Biointerface Research in Applied Chemistry 10 (3), 5507-5511, 2020
142020
Cardiovascular calcium channel blockers: historical overview, development and new approaches in design
I Drapak, L Perekhoda, T Tsapko, N Berezniakova, Y Tsapko
Journal of Heterocyclic Chemistry 54 (4), 2117-2128, 2017
132017
Synthesis of some С5 substituted 4-phenylimino-thiazolidin-2-ones as possible anti-inflammatory agents
CT Сhulovska Z, I Drapak, I Chaban, I Nektegaev
Biointerface Res. Appl. Chem 11 (1), 8009-8017, 2021
122021
HPLC method development for the analysis of bisoprolol in combined dosage form containing bisoprolol and enalapril and in vitro dissolution studied
L Logoyda, S Kovalenko, AМ Abdel-Megied, I Zhulkevych, I Drapak, ...
102019
The antioxidant properties of 1-[2-(R-phenylimino)-4-methyl-3-(3-[morpholine-4yl] propyl)-2, 3-dihydro-1, 3-thiazol-5-yl] ethane-1-one derivatives under conditions of …
LO Perekhoda, NP Kobzar, HO Yeromina, IV Drapak
102017
Approaches for synthesis and chemical modification of non-condensed heterocyclic systems based on 1, 3, 4-oxadiazole ring and their biological activity: A review
M Lelyukh, M Martynets, M Kalytovska, I Drapak, S Harkov, T Chaban, ...
Journal of Applied Pharmaceutical Science 10 (10), 151-165, 2020
92020
Synthesis and in silico research of derivatives of 3-allyl-4-(R-phenyl)-N-(R1-phenyl) thiazole-2-imine
LO Perekhoda, MM Suleiman, IA Sych, VD Yaremenko, IV Drapak
92017
A review on synthetic routes for obtaining of 2, 5-disubstituted 1, 3, 4-oxadiazoles via cyclodehydration and oxidative cyclization reactions
M Lelyukh, I Chaban, L Shelepeten, I Demchuk, S Harkov, T Chaban, ...
Biointerface Research in Applied Chemistry 10 (4), 5960-5971, 2020
82020
Synthesis, anticancer and antioxidant properties of some 4-thioxo-thiazolidin-2-ones
Z Chulovska, I Drapak, T Chaban, V Ogurtsov, I Chaban, V Matiychuk
European Chemical Bulletin 10 (3), 147-154, 2021
72021
Search for Biologically Active Substances with Antimicrobial and Antifungal Action in the series of 2.5-disubstituted 1, 3, 4-tiadiazoles
IV Sych, IV Drapak, MM Suleiman, MV Rakhimova, NP Kobzar, IA Sych, ...
Res J Pharm Tech 12 (6), 1-6, 2019
72019
The use of the docking studies with the purpose of searching potential cardioprotectors
I Drapak, L Perekhoda, O Vynogradova, M Protopopov, M Suleiman, ...
Pharmacia 2, 40-46, 2018
72018
Development of a Novel, Fast, Simple HPLC method for determination of atorvastatin and its impurities in tablets
N Shulyak, M Piponski, S Kovalenko, T Bakovska Stoimenova, ...
Scientia Pharmaceutica 89 (2), 16, 2021
62021
Cardioprotective activity of some 2-arylimino-1, 3-thiazole derivatives
I Drapak, L Perekhoda, N Demchenko, M Suleiman, M Rakhimova, ...
Scientia Pharmaceutica 87 (1), 7, 2019
62019
Докінгові дослідження та QSAR-аналіз 4-(3, 5-діарил-4, 5-дигідро-1-1Н-піразол-1-іл) пропіонової кислоти), які виявляють протиракову активність in vitro
ДЯ Гаврилюк, БС Зіменковський, ІВ Драпак, ВВ Атаманюк, РБ Лесик
Фарм журн 6, 69-75, 2009
62009
QSAR-analysis of 1-[2-(R-phenylimino)-4-methyl-3-(3-[morpholine-4-yl] propyl)-2, 3-dihydro-1, 3-thiazol-5-yl] ethane-1-one’s derivatives as potential antioxidants
І Drapak, B Zimenkovsky, L Perekhoda, H Yeromina, K Lipakova, ...
Pharmacia 66 (1), 33-40, 2019
52019
Historical overview, development and new approaches in design of angiotensin converting enzyme inhibitors and angiotensin receptor antagonists. Part I
I Drapak, O Kamenetska, L Perekhoda, I Sych
Scripta Scientifica Pharmaceutica 3 (1), 19-33, 2016
52016
У даний момент система не може виконати операцію. Спробуйте пізніше.
Статті 1–20